// App-Quantinova.ai

4888 : Antibody blockade of semaphorin 4D breaks down stromal barriers to enhance tumoricidal immune infiltration, supporting rational immunotherapy combinations

Researchers

Presenter

  • Elizabeth E. Evans

Principal Investigators

  • Holm Bussler

  • Sebold Torno

  • Crystal Mallow

  • Christine Reilly

  • Maria Scrivens

  • Ekaterina Klimatcheva

  • Laurie A. Winter

  • Renee Kirk

  • Alan Howell

  • Leslie Balch

  • John E. Leonard

  • Mark Paris

  • Terrence L. Fisher

  • Siwen Hu-Lieskovan

  • Antoni Ribas

  • Ernest S. Smith

  • Maurice Zauderer

Medical Centers

  • Vaccinex, Rochester, NY

  • David Geffen School of Medcn at UCLA, Los Angeles, CA

  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • VX15

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved